ClinicalTrialsFinder
RecruitingNCT06308055

Abiomed Impella RT-DAQ - Observational Study

Abiomed IMPELLA-RT-DAQ - Impella Real Time Data AcQuisition

Sponsor

Abiomed Inc.

Enrollment

125 participants

Start Date

Oct 4, 2024

Study Type

OBSERVATIONAL

Conditions

Cardiogenic Shock

Summary

Abiomed IMPELLA-RT-DAQ - Impella Real Time Data AcQuisition

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Data Acquisition for people with cardiogenic shock. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERData Acquisition

Develop algorithms for determining the cardiac output through the synchronous acquisition of hemodynamic data from the pulmonary artery catheter or other pressure sensors and Impella using a network module.

Locations(4)

Uniklinik RWTH Aachen

Aachen, North Rhine-Westphalia, Germany

UKSH Campus Kiel

Kiel, Schleswig-Holstein, Germany

IRCCS Ospedale San Raffaele

Milan, MI, Italy

Universitätsspital Basel

Basel, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06308055

Related Trials

Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE

NCT075155084 locations

Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock

NCT072939238 locations

COMPARE-VENT Feasibility Pilot Study

NCT076562591 location

Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO

NCT056990051 location

Cardiovascular Outcomes Registry in Cardiogenic SHOCK (COR-SHOCK)

NCT075972911 location